WENDI NEAL: Open Payments
NPI 1396200960 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 33 payments from 4 companies in 2025. Trend: 2023 $1,448 · 2024 $579 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $444 |
| Madrigal Pharmaceuticals | 1 | $128 |
| GENZYME CORPORATION | 2 | $35 |
| Novo Nordisk Inc | 1 | $17 |
Products named: RINVOQ, REZDIFFRA, SKYRIZI, LINZESS, DUPIXENT, Wegovy.
Industry payments across LA — which companies pay providers there.
